Abbott Laboratories (ABT) Gains from Investment Securities (2016)
Abbott Laboratories (ABT) posted Gains from Investment Securities of -$1.0 million for Q4 2016, down 125.0% sequentially from $4.0 million in Q3 2016.
Abbott Laboratories (ABT) Gains from Investment Securities (2016) Analysis & Trends
Abbott Laboratories has reported Gains from Investment Securities for 1 years, with the latest figure at -$1.0 million in Q4 2016.
- Quarterly Gains from Investment Securities changed N/A year-over-year to -$1.0 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $480.0 million (changed N/A YoY) and the FY2016 annual result came in at $480.0 million, changed N/A from the prior year.
- Gains from Investment Securities eased to -$1.0 million in Q4 2016 per ABT's latest filing, from $4.0 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $477.0 million in Q1 2016 and troughed at -$1.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -1.00 Mn |
| Dec 31, 2016 | -1.00 Mn |
| Sep 30, 2016 | 4.00 Mn |
| Sep 30, 2016 | 4.00 Mn |
| Mar 31, 2016 | 477.00 Mn |
| Mar 31, 2016 | 477.00 Mn |